Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Horizon Therapeutics plc

https://www.horizontherapeutics.com

Latest From Horizon Therapeutics plc

AGTC Moves Past Biogen With Ophthalmic Gene Therapy

AGTC hopes to gain the first approval in X-linked retinitis pigmentosa for its gene therapy AGTC-501, now in a Phase II/III study. It also is advancing development in achromatopsia, another unmet medical need.

Gene Therapy Rare Diseases

Alexion’s Phase III Data Position Ultomiris For Expansion Into Myasthenia Gravis

As its acquisition by AstraZeneca moves toward closure, Alexion plans to file the Soliris follow-on for generalized myasthenia gravis in the US, EU and Japan. But potential competition awaits in the C5 inhibitor and FcRn antagonist classes.

Life Cycle Management Research and Development Strategies

Stock Watch: Why Have Biotech Acquisitions Paused?

The subdued number of acquisitions of biotech by big pharma has more than one cause. The structural improvement of the process of drug discovery and development at big pharma is the main one.

M & A Stock Watch

Finance Watch: US, Hong Kong IPOs Are Hot, But Sirnaomics Stays Private

Private Company Edition: Sirnaomics planned to go public after its series D, but its new venture capital does not prevent it from doing so in the near term. Also, Vida Ventures and Novalis Biotech raised new VC funds to back start-ups and ArriVent launched with up to $150m in series A cash.

Financing Innovation
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Bio-Technology General Corporation
    • Crealta Holdings LLC
    • Crealta Pharmaceuticals
    • Curzion Pharmaceuticals, Inc.
    • Encode Pharmaceuticals, Inc.
    • Horizon Pharma plc
    • Hyperion Therapeutics, Inc. (Andromeda Biotech Ltd)
    • Nitec Pharma AG
    • Raptor Pharmaceutical Corp.
    • River Vision Development Corp.
    • Savient Pharmaceuticals, Inc. (SVNT)
    • TorreyPines Therapeutics, Inc. (Neurogenetics Inc.)
    • Vidara Therapeutics Inc
    • Viela Bio, Inc.
UsernamePublicRestriction

Register